Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 130.00
+1.00 (0.78%)
Sep 30, 2025, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 19.26 billion as of September 30, 2025. Its market cap has decreased by -9.72% in one year.
Market Cap
19.26B
Enterprise Value
16.94B
Revenue
10.88B
Ranking
n/a
PE Ratio
14.47
Stock Price
130.00
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 19.26B, an increase of 729.18%. That is a compound annual growth rate of 6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 19.11B | -13.71% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | 24.19B | -8.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 286.16B |
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |